Global Biobank Market By Product Overview
Biobank market accounted for US$ 62.9 billion in 2020 and is estimated to be US$ 113.2 billion by 2030 and is anticipated to register a CAGR of 6.1%.
A biobank is a sort of biorepository that stores organic examples (generally human) for use in research. Biobanks have become a significant asset in clinical exploration, supporting numerous sorts of contemporary examination like genomics and customized medication. Biobanks can give scientists admittance to information addressing countless individuals. Tests in biobanks and the information got from those examples can frequently be utilized by numerous specialists for cross reason research considers. For instance, numerous sicknesses are related with single-nucleotide polymorphisms. Genome-wide affiliation considers utilizing information from tens or countless people can recognize these hereditary relationship as potential sickness biomarkers. Numerous analysts attempted to obtain adequate examples before the coming of biobanks. A repository which collects biological samples and data associated with genes and samples is referred as biobank or biorepository. Biobank stores these samples for research and healthcare product development purpose. Biobanks are located at hospitals, research institutions or they are also present as standalone.
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Global Biobank Market By Product Drivers & Restraints
Increasing trends towards gene based clinical study
Furthermore, increasing trend towards gene based clinical study is playing a major role in development of drugs for critical diseases across the globe favors the growth of biobank market. As genetic structure helps to understand the disease causing factor, its genetic base, which is useful to develop disease specific treatment.
Increasing personalized therapy
Increasing personalized therapy and increasing prevalence and incidence of various diseases such as chronic disease are the major factors driving growth of the biobank market. Biobank also plays an important role in clinical studies by providing their research analysis and through support such as providing samples of various living organisms for medical test.
Moreover, some biobank help research studies by recruiting candidates for research trials and also helps for further research study by availing their labs and technicians. The stringent regulations and guidelines make this task challenging for biobanks. However, construction and maintenance of biobank requires high capital investment. Also it requires highly skilled laboratory technicians to handle biological samples, which increases the overall handling cost. This are the factors expected to hamper growth of the biobank market up to a certain extent.
Global Biobank Market By Product Segmentations & Regional Insights
Biobank market has been segmented on the basis of product type, bio-preservation media type, application, end user, and region.
The product type segment includes equipment, consumables, and systems. Also, on the basis of bio-preservation media type the target market is segmented into optimized pre-formulated media and non-optimized isotonic formulation media.
On the basis of application, the biobank market has been segmented into regenerative medicine, bio banking, and drug discovery/clinical research. Moreover, end user segment includes research organizations, diagnostic clinical centers, and others.
On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is expected to account major market share as compared to that of other regions.
Regional Insights:
On the basis of region, the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America will keep on ruling the worldwide market in the estimate time frame. Notwithstanding, Asia-Pacific is relied upon to witness the most elevated CAGR, with the development in this market focused at Japan, China, and India. Further developing life sciences research foundation in arising economies and developing government interest in biomedical, drug, and biotechnology enterprises are a portion of the elements pushing market development in the Asia-Pacific area.
Attribute |
Details |
Base year for estimation |
2020 |
Forecast period |
2020 – 2030 |
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
Market Segmentation |
By Product type- Equipment, Consumables, And Systems By Bio-preservation media type- Optimized Pre-Formulated Media And Non-Optimized Isotonic Formulation Media By Application– Regenerative Medicine, Bio Banking, And Drug Discovery/Clinical Research. By End-User– Research Organizations, Diagnostic Clinical Centers, And Others |
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global Automated Border Control market report based on product type, bio-preservation media type, application, end-user and region.
Global Single Cell Genomics Sequencing Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
-
- U.S.
- Canada
- Middle East & Africa
Global Biobank Market By Product Competitive Landscape & Key Players
Key players operating in the biobank market includes Biolife Solutions Inc., PHC Corporation, Thermo Fisher Scientific Inc., Beckman Coulter, Inc., BioCision, Taylor-Wharton International, VWR International, and So-Low Environmental Equipment Co.
Global Biobank Market By Product Company Profile
- Biolife Solutions Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- PHC Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Beckman Coulter, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- BioCision
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Taylor-Wharton International
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- VWR International
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- So-Low Environmental Equipment Co.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Global Biobank Market By Product Highlights
FAQs
Global Biobank Market is segmented, By Product Type (Equipment, and Consumables), By Application (Regenerative medicine, Bio banking, and Drug discovery/Clinical research), and By End User (Research organizations, Diagnostic clinical centers, and others)
Increasing personalized therapy and increasing prevalence and incidence of various diseases such as chronic disease are the major factors driving growth of the global biobank market.
Key players operating in the global biobank market includes Biolife Solutions Inc., PHC Corporation, Thermo Fisher Scientific Inc., Beckman Coulter, Inc., BioCision, Taylor-Wharton International, VWR International, and So-Low Environmental Equipment Co.